You are currently on the new version of our website. Access the old version .

28 Results Found

  • Article
  • Open Access
10 Citations
4,023 Views
17 Pages

22 November 2022

Doxorubicin (Dox) is a widely utilized chemotherapeutic; however, it carries side effects, including drug-induced immune thrombocytopenia (DITP) and increased risk of venous thromboembolism (VTE). Currently, the mechanisms for Dox-associated DITP and...

  • Article
  • Open Access
25 Citations
4,570 Views
22 Pages

Tumor-Educated Platelet Extracellular Vesicles: Proteomic Profiling and Crosstalk with Colorectal Cancer Cells

  • Annalisa Contursi,
  • Rosa Fullone,
  • Paulina Szklanna-Koszalinska,
  • Simone Marcone,
  • Paola Lanuti,
  • Francesco Taus,
  • Alessandra Meneguzzi,
  • Giulia Turri,
  • Melania Dovizio and
  • Annalisa Bruno
  • + 7 authors

5 January 2023

Background: Platelet–cancer cell interactions modulate tumor metastasis and thrombosis in cancer. Platelet-derived extracellular vesicles (EVs) can contribute to these outcomes. Methods: We characterized the medium-sized EVs (mEVs) released by...

  • Editorial
  • Open Access
5 Citations
2,273 Views
3 Pages

Molecular Research on Platelet Activity in Health and Disease

  • Maria Valeria Catani,
  • Isabella Savini and
  • Valeria Gasperi

This editorial summarizes and discusses the themes of eleven articles (five reviews and six original studies) published in the Special Issue “Molecular Research On Platelet Activity in Health and Disease”. They give an international pictu...

  • Review
  • Open Access
72 Citations
9,926 Views
15 Pages

Cancer patients experience a four-fold increase in thrombosis risk, indicating that cancer development and progression are associated with platelet activation. Xenograft experiments and transgenic mouse models further demonstrate that platelet activa...

  • Article
  • Open Access
9 Citations
3,287 Views
15 Pages

Adhesion of Platelets to Colon Cancer Cells Is Necessary to Promote Tumor Development in Xenograft, Genetic and Inflammation Models

  • Marica Cariello,
  • Elena Piccinin,
  • Roberta Zerlotin,
  • Marilidia Piglionica,
  • Claudia Peres,
  • Chiara Divella,
  • Anna Signorile,
  • Gaetano Villani,
  • Giuseppe Ingravallo and
  • Carlo Sabbà
  • + 1 author

23 August 2021

Platelets represent the linkage between tissue damage and inflammatory response with a putative role in tumorigenesis. Given the importance of the microenvironment in colon cancer development, we elucidated the eventual role of platelets-cancer cells...

  • Review
  • Open Access
72 Citations
7,603 Views
15 Pages

5 November 2021

Platelets are conventionally defined as playing a vital role in homeostasis and thrombosis. This role has over the years transformed as knowledge regarding platelets has expanded to include inflammation, cancer progression, and metastasis. Upon plate...

  • Article
  • Open Access
4 Citations
3,530 Views
18 Pages

Blockade of Platelet CysLT1R Receptor with Zafirlukast Counteracts Platelet Protumoral Action and Prevents Breast Cancer Metastasis to Bone and Lung

  • Lou Saier,
  • Johnny Ribeiro,
  • Thomas Daunizeau,
  • Audrey Houssin,
  • Gabriel Ichim,
  • Caroline Barette,
  • Lamia Bouazza and
  • Olivier Peyruchaud

13 October 2022

Metastases are the main cause of death in cancer patients, and platelets are largely known for their contribution in cancer progression. However, targeting platelets is highly challenging given their paramount function in hemostasis. Using a high-thr...

  • Article
  • Open Access
4 Citations
4,021 Views
15 Pages

Crosstalk between Cancer Cells and Fibroblasts for the Production of Monocyte Chemoattractant Protein-1 in the Murine 4T1 Breast Cancer

  • Mayu Imamura,
  • Tiantian Li,
  • Chunning Li,
  • Masayoshi Fujisawa,
  • Naofumi Mukaida,
  • Akihiro Matsukawa and
  • Teizo Yoshimura

22 October 2021

The chemokine monocyte chemoattractant protein-1 (MCP-1/CCL2) is shown to promote the progression of breast cancer. We previously identified cancer cell-derived granulocyte-macrophage colony-stimulating factor (GM-CSF) as a potential regulator of MCP...

  • Review
  • Open Access
80 Citations
8,667 Views
17 Pages

Platelets as Key Factors in Hepatocellular Carcinoma

  • Natasa Pavlovic,
  • Bhavna Rani,
  • Pär Gerwins and
  • Femke Heindryckx

20 July 2019

Hepatocellular carcinoma (HCC) is a primary liver cancer that usually develops in the setting of chronic inflammation and liver damage. The hepatic microenvironment plays a crucial role in the disease development, as players such as hepatic stellate...

  • Article
  • Open Access
15 Citations
4,703 Views
15 Pages

Exosomal HMGB1 Promoted Cancer Malignancy

  • Jiaan-Der Wang,
  • Ya-Yu Wang,
  • Shih-Yi Lin,
  • Cheng-Yi Chang,
  • Jian-Ri Li,
  • Shi-Wei Huang,
  • Wen-Ying Chen,
  • Su-Lan Liao and
  • Chun-Jung Chen

19 February 2021

Reciprocal crosstalk between platelets and malignancies underscores the potential of antiplatelet therapy in cancer treatment. In this study, we found that human chronic myeloid leukemia K562 cell-differentiated megakaryocytes and murine platelets pr...

  • Article
  • Open Access
15 Citations
3,686 Views
15 Pages

11 November 2021

Tumor cell crosstalk with platelets and, subsequently, their activation are key steps in hematogenous tumor metastasis. MACC1 is an oncogene involved in molecular pathogenesis of colorectal cancer (CRC) and other solid tumor entities, mediating motil...

  • Review
  • Open Access
18 Citations
5,062 Views
37 Pages

Crosstalk of Immune Cells and Platelets in an Ovarian Cancer Microenvironment and Their Prognostic Significance

  • Katarzyna Aneta Pankowska,
  • Grażyna Ewa Będkowska,
  • Joanna Chociej-Stypułkowska,
  • Małgorzata Rusak,
  • Milena Dąbrowska and
  • Joanna Osada

Ovarian cancer (OC) is one of the deadliest gynecological cancers, largely due to the fast development of metastasis and drug resistance. The immune system is a critical component of the OC tumor microenvironment (TME) and immune cells such as T cell...

  • Review
  • Open Access
52 Citations
8,693 Views
17 Pages

Involvement of Extracellular Vesicles in Vascular-Related Functions in Cancer Progression and Metastasis

  • Shinsuke Kikuchi,
  • Yusuke Yoshioka,
  • Marta Prieto-Vila and
  • Takahiro Ochiya

The primary cause of mortality among patients with cancer is the progression of the tumor, better known as cancer invasion and metastasis. Cancer progression involves a series of biologically important steps in which the cross-talk between cancer cel...

  • Review
  • Open Access
48 Citations
5,243 Views
18 Pages

Platelets Extracellular Vesicles as Regulators of Cancer Progression—An Updated Perspective

  • Magdalena Żmigrodzka,
  • Olga Witkowska-Piłaszewicz and
  • Anna Winnicka

Extracellular vesicles (EVs) are a diverse group of membrane-bound structures secreted in physiological and pathological conditions by prokaryotic and eukaryotic cells. Their role in cell-to-cell communications has been discussed for more than two de...

  • Review
  • Open Access
45 Citations
7,051 Views
18 Pages

Novel Aspects of Extracellular Vesicles as Mediators of Cancer-Associated Thrombosis

  • Vitor H. Almeida,
  • Araci M. R. Rondon,
  • Tainá Gomes and
  • Robson Q. Monteiro

13 July 2019

The establishment of prothrombotic states during cancer progression is well reported but the precise mechanisms underlying this process remain elusive. A number of studies have implicated the presence of the clotting initiator protein, tissue factor...

  • Article
  • Open Access
42 Citations
7,322 Views
19 Pages

Antiplatelet Drug Ticagrelor Enhances Chemotherapeutic Efficacy by Targeting the Novel P2Y12-AKT Pathway in Pancreatic Cancer Cells

  • Omar Elaskalani,
  • Alice Domenichini,
  • Norbaini Binti Abdol Razak,
  • Danielle E. Dye,
  • Marco Falasca and
  • Pat Metharom

20 January 2020

Background: Extensive research has reported that extracellular ADP in the tumour microenvironment can stimulate platelets through interaction with the platelet receptor P2Y12. In turn, activated platelets release biological factors supporting cancer...

  • Article
  • Open Access
2 Citations
2,961 Views
13 Pages

Mass Spectrometry and Pharmacological Approaches to Measuring Cooption and Reciprocal Activation of Receptor Tyrosine Kinases

  • Jason Linzer,
  • Zachary Phelps,
  • Shivasuryan Vummidi,
  • Bo Young Elizabeth Lee,
  • Nicolas Coant and
  • John D. Haley

Receptor tyrosine kinases (RTKs) can show extensive crosstalk, directly and indirectly. Elucidating RTK crosstalk remains an important goal in the clinical combination of anti-cancer therapies. Here, we present mass spectrometry and pharmacological a...

  • Article
  • Open Access
8 Citations
4,174 Views
20 Pages

Platelet-Activating Factor Acetylhydrolase Expression in BRCA1 Mutant Ovarian Cancer as a Protective Factor and Potential Negative Regulator of the Wnt Signaling Pathway

  • Yue Liao,
  • Susann Badmann,
  • Till Kaltofen,
  • Doris Mayr,
  • Elisa Schmoeckel,
  • Eileen Deuster,
  • Mareike Mannewitz,
  • Sarah Landgrebe,
  • Thomas Kolben and
  • Anna Hester
  • + 6 authors

Aberrantly activated Wnt/β-catenin signaling pathway, as well as platelet-activating factor (PAF), contribute to cancer progression and metastasis of many cancer entities. Nonetheless, the role of the degradation enzyme named platelet-activating fact...

  • Review
  • Open Access
30 Citations
11,588 Views
31 Pages

Growth Factor Mediated Signaling in Pancreatic Pathogenesis

  • Debashis Nandy and
  • Debabrata Mukhopadhyay

24 February 2011

Functionally, the pancreas consists of two types of tissues: exocrine and endocrine. Exocrine pancreatic disorders mainly involve acute and chronic pancreatitis. Acute pancreatitis typically is benign, while chronic pancreatitis is considered a risk...

  • Article
  • Open Access
66 Citations
5,247 Views
21 Pages

Carcinoma-Associated Mesenchymal Stem Cells Promote Chemoresistance in Ovarian Cancer Stem Cells via PDGF Signaling

  • Shreya Raghavan,
  • Catherine S. Snyder,
  • Anni Wang,
  • Karen McLean,
  • Dmitriy Zamarin,
  • Ronald J. Buckanovich and
  • Geeta Mehta

27 July 2020

Within the ovarian cancer tumor microenvironment, cancer stem-like cells (CSC) interact with carcinoma associated mesenchymal stem/stromal cells (CA-MSC) through multiple secreted cytokines and growth factors. These paracrine interactions have been r...

  • Article
  • Open Access
50 Citations
6,082 Views
17 Pages

Factors Secreted by Cancer-Associated Fibroblasts that Sustain Cancer Stem Properties in Head and Neck Squamous Carcinoma Cells as Potential Therapeutic Targets

  • Saúl Álvarez-Teijeiro,
  • Cristina García-Inclán,
  • M. Ángeles Villaronga,
  • Pedro Casado,
  • Francisco Hermida-Prado,
  • Rocío Granda-Díaz,
  • Juan P. Rodrigo,
  • Fernando Calvo,
  • Nagore Del-Río-Ibisate and
  • Alberto Gandarillas
  • + 4 authors

17 September 2018

This study investigates for the first time the crosstalk between stromal fibroblasts and cancer stem cell (CSC) biology in head and neck squamous cell carcinomas (HNSCC), with the ultimate goal of identifying effective therapeutic targets. The effect...

  • Article
  • Open Access
7 Citations
3,843 Views
17 Pages

6 July 2022

Circulating tumor cells (CTCs) crosstalk with different blood cells before a few of them settle down as disseminated tumor cells (DTCs). We evaluated the correlation between CTC subtypes, DTCs and the neutrophil to lymphocyte ratio (NLR), platelet to...

  • Article
  • Open Access
4 Citations
2,856 Views
14 Pages

Eukaryotic and prokaryotic cells in physiological and pathological conditions form membrane-bound extracellular vesicles, known as EVs. The ability of these submicron structures to transfer their cargoes (miRNA, DNA, protein, cytokines, receptors, et...

  • Article
  • Open Access
23 Citations
9,077 Views
18 Pages

Multiple Mechanisms Mediate Resistance to Sorafenib in Urothelial Cancer

  • Judith Knievel,
  • Wolfgang A. Schulz,
  • Annemarie Greife,
  • Christiane Hader,
  • Tobias Lübke,
  • Ingo Schmitz,
  • Peter Albers and
  • Günter Niegisch

7 November 2014

Genetic and epigenetic changes in the mitogen activated protein kinase (MAPK) signaling render urothelial cancer a potential target for tyrosine kinase inhibitor (TKI) treatment. However, clinical trials of several TKIs failed to prove efficacy. In t...

  • Article
  • Open Access
8 Citations
3,550 Views
19 Pages

CP-673451, a Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces Apoptosis in Opisthorchis viverrini-Associated Cholangiocarcinoma via Nrf2 Suppression and Enhanced ROS

  • Jinchutha Duangdara,
  • Boonyakorn Boonsri,
  • Apinya Sayinta,
  • Kittiya Supradit,
  • Pakpoom Thintharua,
  • Supeecha Kumkate,
  • Chinnawut Suriyonplengsaeng,
  • Noppadol Larbcharoensub,
  • Somkit Mingphruedhi and
  • Narongsak Rungsakulkij
  • + 8 authors

20 December 2023

Platelet-derived growth factors (PDGFs) and PDGF receptors (PDGFRs) play essential roles in promoting cholangiocarcinoma (CCA) cell survival by mediating paracrine crosstalk between tumor and cancer-associated fibroblasts (CAFs), indicating the poten...

  • Article
  • Open Access
14 Citations
4,041 Views
18 Pages

12 November 2020

Microvesicle particles (MVP) secreted by a variety of cell types in response to reactive oxygen species (ROS)-generating pro-oxidative stressors have been implicated in modifying the cellular responses including the sensitivity to therapeutic agents....

  • Review
  • Open Access
93 Views
27 Pages

Bone metastases mark a critical and often terminal phase in cancer progression, where disseminated tumor cells (DTCs) manage to infiltrate and exploit the complex microenvironments of the bone marrow. While most current therapies focus on the well-kn...

  • Article
  • Open Access
8 Citations
2,074 Views
14 Pages

Portrait of the Inflammatory Response to Radioiodine Therapy in Female Patients with Differentiated Thyroid Cancer with/without Type 2 Diabetes Mellitus

  • Adina Elena Stanciu,
  • Anca Hurduc,
  • Marcel Marian Stanciu,
  • Mirela Gherghe,
  • Dan Cristian Gheorghe,
  • Virgiliu Mihail Prunoiu and
  • Adina Zamfir-Chiru-Anton

26 July 2023

No clinical studies have investigated the effect of radioiodine (131I)-targeted therapy on the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as inflammatory response markers in patients with differentiated thyroid cancer...